Immunotherapy in pediatric malignancies: current status and future perspectives
We are experimenting with display styles that make it easier to read articles in PMC. The ePub format uses eBook readers, which have several "ease of reading" features already built in.
Future Oncol . Author manuscript; available in PMC: 2016 Mar 16. Published in final edited form as: Future Oncol. 2014;10(9):1659–1678. doi: 10.2217/fon.14.62 Immunotherapy in pediatric malignancies: current status and future perspectives Christian M Capitini Christian M Capitini 1 Department of Pediatrics and Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, 1111 Highland Ave., WIMR 4137, Madison, WI 53705 Find articles by Christian M Capitini 1 , Mario Otto Mario Otto 1 Department of Pediatrics and Carbone Cancer Center, University of Wisconsin School of Me
saved by
related reading
- Hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes in children and adolescentsuptodate.com
- Acute myeloid leukemia: Children and adolescentsuptodate.com
- Acute myeloid leukemia: Children and adolescentsuptodate.com
- Immunotherapy for Cancer - NCIcancer.gov
- Neoadjuvant immune checkpoint blockade in high-risk resectable melanomanature.com
- Cancer cells educate natural killer cells to a metastasis-promoting cell state - PMCpmc.ncbi.nlm.nih.gov
- Childhood leukemia: how a deadly cancer became treatableourworldindata.org
- Cancer cells educate natural killer cells to a metastasis-promoting cell state - PubMedpubmed.ncbi.nlm.nih.gov
- The current state of the art and future trends in RAS-targeted cancer therapiesnature.com
- Current and Emerging Approaches for Spine Tumor Treatmentpmc.ncbi.nlm.nih.gov
- Frontiers | Therapeutic Antibodies against Intracellular Tumor Antigensfrontiersin.org
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemianature.com